Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
2.530
+0.050 (2.02%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Lisata Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 16.21 | 22.59 | 32.15 | 24.65 | 16.51 | Upgrade
|
| Short-Term Investments | 15.04 | 27.94 | 37.07 | 70.32 | 18.06 | Upgrade
|
| Cash & Short-Term Investments | 31.25 | 50.54 | 69.23 | 94.97 | 34.57 | Upgrade
|
| Cash Growth | -38.17% | -27.00% | -27.11% | 174.69% | 37.43% | Upgrade
|
| Accounts Receivable | 0.9 | - | - | - | - | Upgrade
|
| Other Receivables | 0.9 | - | 0.7 | - | - | Upgrade
|
| Receivables | 1.8 | - | 0.7 | - | - | Upgrade
|
| Prepaid Expenses | 1.53 | 3.39 | 1.95 | 1.21 | 0.76 | Upgrade
|
| Total Current Assets | 34.58 | 53.92 | 71.88 | 96.18 | 35.33 | Upgrade
|
| Property, Plant & Equipment | 0.21 | 0.48 | 0.78 | 0.79 | 0.63 | Upgrade
|
| Other Intangible Assets | 0.19 | 0.26 | 0.33 | - | - | Upgrade
|
| Other Long-Term Assets | 0.02 | 0.02 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Total Assets | 35 | 54.69 | 73.03 | 97.01 | 36 | Upgrade
|
| Accounts Payable | 1.28 | 2.42 | 2.66 | 1.93 | 1.02 | Upgrade
|
| Accrued Expenses | 4.19 | 4 | 3.55 | 2.36 | 2.12 | Upgrade
|
| Current Portion of Leases | 0.14 | 0.17 | 0.18 | 0.23 | 0.37 | Upgrade
|
| Total Current Liabilities | 5.61 | 6.59 | 6.38 | 4.52 | 3.51 | Upgrade
|
| Long-Term Leases | - | 0.14 | 0.31 | 0.49 | 0.25 | Upgrade
|
| Other Long-Term Liabilities | 0.07 | 0.07 | 0.02 | - | - | Upgrade
|
| Total Liabilities | 5.69 | 6.8 | 6.71 | 5.01 | 3.76 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 578.42 | 576.97 | 574.55 | 546.04 | 458.75 | Upgrade
|
| Retained Earnings | -548.07 | -528.08 | -507.24 | -453.02 | -425.55 | Upgrade
|
| Treasury Stock | -0.71 | -0.71 | -0.71 | -0.71 | -0.71 | Upgrade
|
| Comprehensive Income & Other | -0.08 | -0.04 | -0.03 | -0.07 | -0.01 | Upgrade
|
| Total Common Equity | 29.57 | 48.15 | 66.58 | 92.25 | 32.5 | Upgrade
|
| Minority Interest | -0.25 | -0.25 | -0.25 | -0.25 | -0.25 | Upgrade
|
| Shareholders' Equity | 29.32 | 47.89 | 66.32 | 92 | 32.24 | Upgrade
|
| Total Liabilities & Equity | 35 | 54.69 | 73.03 | 97.01 | 36 | Upgrade
|
| Total Debt | 0.14 | 0.31 | 0.49 | 0.71 | 0.62 | Upgrade
|
| Net Cash (Debt) | 31.11 | 50.23 | 68.74 | 94.26 | 33.95 | Upgrade
|
| Net Cash Growth | -38.07% | -26.93% | -27.07% | 177.64% | 40.41% | Upgrade
|
| Net Cash Per Share | 3.73 | 6.22 | 13.27 | 25.56 | 32.98 | Upgrade
|
| Filing Date Shares Outstanding | 27.7 | 8.31 | 8 | 4.04 | 3.97 | Upgrade
|
| Total Common Shares Outstanding | 8.41 | 8.15 | 7.87 | 3.99 | 1.29 | Upgrade
|
| Working Capital | 28.97 | 47.33 | 65.49 | 91.66 | 31.83 | Upgrade
|
| Book Value Per Share | 3.52 | 5.91 | 8.46 | 23.14 | 25.15 | Upgrade
|
| Tangible Book Value | 29.38 | 47.89 | 66.24 | 92.25 | 32.5 | Upgrade
|
| Tangible Book Value Per Share | 3.49 | 5.88 | 8.42 | 23.14 | 25.15 | Upgrade
|
| Machinery | 0.59 | 0.59 | 0.61 | 0.34 | 0.28 | Upgrade
|
| Leasehold Improvements | 0.07 | 0.07 | 0.1 | 0.09 | 0.09 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.